Key Takeaways
- • Protego Ventures closed its debut fund at $125 million, falling short of its $150 million target but establishing Israel's first dedicated venture vehicle focused on early-growth defense technology companies.
- • The fund will deploy $5 million to $15 million per portfolio company, targeting Israeli startups with battlefield-proven technologies and operational validation from the Israel Defense Forces and allied militaries.
- • Portfolio company XTEND completed an initial public offering on the New York Stock Exchange at a $1.5 billion valuation, providing an early validation of the fund's investment thesis around Israeli defense-tech commercialization.
- • Protego was founded by defense ecosystem veterans Lital Leshem and Lee Moser to capitalize on a structural gap: global defense spending has risen 50% over the past decade, while venture investment in defense technology reached $19.8 billion in Q1 2026, yet Israeli companies with real operational deployment experience remain underinvested relative to their market potential.
- • The fund's strategy targets companies that have already transitioned from development to deployment, leveraging frontline feedback loops that produce technologies faster, leaner, and more scalable than traditional procurement channels.
Summary
Protego Ventures has completed the final close of its debut fund at $125 million in capital commitments, establishing what the firm describes as Israel's first dedicated venture capital vehicle focused on early-growth defense technology companies. The fund closed below its original $150 million target, according to multiple sources, with the final close combining an initial $70 million tranche with a subsequent $55 million addition. The completion of Fund I marks a significant milestone for Israeli defense-tech venture investment at a time of accelerating global defense spending and geopolitical tensions.
The fund's investment strategy targets Israeli startups with battlefield-proven technologies and operational validation. Protego will deploy between $5 million and $15 million per portfolio company, focusing on firms that have already moved from development into active deployment within the Israel Defense Forces and allied militaries. Co-founder and Managing Partner Lital Leshem articulated the firm's core thesis: "Many of the best defense companies in the world are being built right now, in Israel, under real operational demands, iterating according to real frontline conditions, for real customers." This operational feedback loop, according to Leshem, produces technologies that are "faster, leaner, scalable and more flexible than almost anything developed through traditional procurement channels."
The timing of Protego's fund closure aligns with significant structural shifts in global defense investment. Global defense spending has increased 50% over the past decade, while venture investment in defense technology reached $19.8 billion in the first quarter of 2026, driven by heightened geopolitical tensions and demand for rapidly deployable systems. According to the partners, this environment has created a distinct opportunity for companies that have already validated their technologies under real operational conditions—a competitive advantage unique to Israeli firms operating within an active defense ecosystem.
The fund's investment thesis received early validation when XTEND, described as Fund I's first portfolio company, completed an initial public offering on the New York Stock Exchange at a $1.5 billion valuation. This successful exit demonstrates the commercial scalability potential of Israeli defense-tech companies backed by institutional venture capital. Protego was founded by Lital Leshem and Lee Moser, both veterans of Israel's defense and intelligence ecosystem, positioning the firm to identify and evaluate companies with deep operational credibility.
The fund's investment strategy targets Israeli startups with battlefield-proven technologies and operational validation. Protego will deploy between $5 million and $15 million per portfolio company, focusing on firms that have already moved from development into active deployment within the Israel Defense Forces and allied militaries. Co-founder and Managing Partner Lital Leshem articulated the firm's core thesis: "Many of the best defense companies in the world are being built right now, in Israel, under real operational demands, iterating according to real frontline conditions, for real customers." This operational feedback loop, according to Leshem, produces technologies that are "faster, leaner, scalable and more flexible than almost anything developed through traditional procurement channels."
The timing of Protego's fund closure aligns with significant structural shifts in global defense investment. Global defense spending has increased 50% over the past decade, while venture investment in defense technology reached $19.8 billion in the first quarter of 2026, driven by heightened geopolitical tensions and demand for rapidly deployable systems. According to the partners, this environment has created a distinct opportunity for companies that have already validated their technologies under real operational conditions—a competitive advantage unique to Israeli firms operating within an active defense ecosystem.
The fund's investment thesis received early validation when XTEND, described as Fund I's first portfolio company, completed an initial public offering on the New York Stock Exchange at a $1.5 billion valuation. This successful exit demonstrates the commercial scalability potential of Israeli defense-tech companies backed by institutional venture capital. Protego was founded by Lital Leshem and Lee Moser, both veterans of Israel's defense and intelligence ecosystem, positioning the firm to identify and evaluate companies with deep operational credibility.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.